SEC Form 4 · accession 0001209191-16-109307
Tvardi Therapeutics, Inc. · TVRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Josef Schoell
Officer — Chief Financial Officer
Period of report
Mar 16, 2016
Accepted (ET)
Mar 17, 2016 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2016 | M | 8,000 | $0.78 | A | 36,000 | D | |
| Common Stock | Mar 16, 2016 | M | 10,000 | $0.85 | A | 46,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.78 | Mar 16, 2016 | M | 8,000 | D | — | Sep 29, 2016 | Common Stock | 8,000 | 0 | D |
| Employee Stock Option (Right to Buy)F1 | $0.85 | Mar 16, 2016 | M | 10,000 | D | — | Sep 8, 2021 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Immediately exercisable.